USP10 Antagonizes c-Myc Transcriptional Activation through SIRT6 Stabilization to Suppress Tumor Formation

被引:173
|
作者
Lin, Zhenghong [1 ]
Yang, Heeyoung [1 ]
Tan, Can [1 ]
Li, Jinping [1 ]
Liu, Zhaojian [1 ]
Quan, Qiu [1 ]
Kong, Sinyi [1 ]
Ye, Junsheng [1 ]
Gao, Beixue [1 ]
Fang, Deyu [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA
来源
CELL REPORTS | 2013年 / 5卷 / 06期
关键词
HISTONE DEACETYLASE SIRT6; GENE-EXPRESSION; CANCER METABOLISM; CELL-CYCLE; E3; LIGASE; P53; RNA; DIFFERENTIATION; LOCALIZATION; DEGRADATION;
D O I
10.1016/j.celrep.2013.11.029
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The reduced protein expression of SIRT6 tumor suppressor is involved in tumorigenesis. The molecular mechanisms underlying SIRT6 protein downregulation in human cancers remain unknown. Using a proteomic approach, we have identified the ubiquitin- specific peptidase USP10, another tumor suppressor, as one of the SIRT6-interacting proteins. USP10 suppresses SIRT6 ubiquitination to protect SIRT6 from proteasomal degradation. USP10 antagonizes the transcriptional activity of the c-Myc oncogene through SIRT6, as well as p53, to inhibit cell-cycle progression, cancer cell growth, and tumor formation. To support this conclusion, we detected significant reductions in both USP10 and SIRT6 protein expression in human colon cancers. Our study discovered crosstalk between two tumor-suppressive genes in regulating cell-cycle progression and proliferation and showed that dysregulated USP10 function promotes tumorigenesis through SIRT6 degradation.
引用
收藏
页码:1639 / 1649
页数:11
相关论文
共 26 条
  • [21] Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling
    Yafang Wang
    Mingyue Yao
    Cheng Li
    Kexin Yang
    Xiaolong Qin
    Lansong Xu
    Shangxuan Shi
    Chengcheng Yu
    Xiangjun Meng
    Chengying Xie
    Experimental Hematology & Oncology, 12
  • [22] Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling
    Wang, Yafang
    Yao, Mingyue
    Li, Cheng
    Yang, Kexin
    Qin, Xiaolong
    Xu, Lansong
    Shi, Shangxuan
    Yu, Chengcheng
    Meng, Xiangjun
    Xie, Chengying
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [23] Hexokinase 2 Promotes Cell Proliferation and Tumor Formation through the Wnt/?-catenin Pathway-mediated Cyclin D1/c-myc Upregulation in Epithelial Ovarian Cancer
    Liu, Xian
    Zuo, Xiaohang
    Sun, Xiaoli
    Tian, Xueye
    Teng, Yue
    JOURNAL OF CANCER, 2022, 13 (08): : 2559 - 2569
  • [24] Erythropoietin protects cell death by inducing EFN-γ through activation of signal pathways triggered by STAT3/c-Myc cascade in mouse islet cells, MIN 6.
    Kim, J. E.
    Jung, J. E.
    Kim, H. S.
    Lee, C. S.
    Chung, M. H.
    Ye, S. K.
    FREE RADICAL RESEARCH, 2006, 40 : S126 - S126
  • [25] ETV6/ARG Oncoprotein Induces Autonomous Cell Growth By Enhancing c-Myc Expression through STAT5 Activation in the Acute Promyelocytic Leukemia Cell Line HT93A
    Iriyama, Noriyoshi
    Hatta, Yoshihiro
    Takei, Masami
    BLOOD, 2014, 124 (21)
  • [26] The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor P27Kip1 to facilitate the activation of Cdk4/6 and early G1 phase progression
    Obaya, AJ
    Kotenko, L
    Cole, MD
    Sedivy, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (34) : 31263 - 31269